Search Options Stock News and Analysis from Schaeffer's

Why You Should Trade Straddles Right Now

https://www.schaeffersresearch.com/content/bgs/2023/03/17/why-you-should-trade-straddles-right-now

3/17/2023 10:26 AM

Subscribers to Chart of the Week received this commentary on Sunday, March 12. Earlier this month, subscribers to our Volatility Trader (VT) service scored an 80% profit on a Pfizer Inc (NYSE:PFE)...

Seagen Stock Boosted on Billion-Dollar Buyout

https://www.schaeffersresearch.com/content/news/2023/03/13/seagen-stock-boosted-on-billion-dollar-buyout

3/13/2023 11:41 AM

Seagen Inc (NASDAQ:SGEN) stock is soaring today, after news that Pfizer (PFE) is acquiring the company for roughly $43 billion, expanding its access to cancer treatment. At last glance, SGEN was up 15...

Pfizer Shares Dismal Sales Outlook Despite Record Revenue

https://www.schaeffersresearch.com/content/news/2023/01/31/pfizer-shares-dismal-sales-outlook-despite-record-revenue

1/31/2023 10:18 AM

Pfizer Inc. (NYSE:PFE) is down 0.8% to trade at $43.22, despite reporting better-than-anticipated fourth-quarter earnings of $1.14 per share, in addition to record revenue of $100.3 billion in 2022....

Earnings Push Wall Street Toward Weekly Wins

https://www.schaeffersresearch.com/content/news/2023/01/27/earnings-push-wall-street-toward-weekly-wins

1/27/2023 2:55 PM

Earnings season was in full swing this week, helping the Dow Jones Industrial Average (DJI) and Nasdaq Composite (IXIC) both log triple-digit gains right out of the gate, while the S&P 500 Index (S...

Analyst: Pfizer's Covid Estimates Need to Drop

https://www.schaeffersresearch.com/content/news/2023/01/26/analyst-pfizers-covid-estimates-need-to-drop

1/26/2023 9:06 AM

UBS downgraded Pfizer Inc. (NYSE:PFE) to "neutral" from "buy" this morning, citing lower Covid-19 expectations. The analyst also slashed its price target to $47 from $55, noting the pharmaceutical gi...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity